3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID
Compound with spectra: 1 NMR
![3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID](/api/compound/DXVbPV7Qw4r.png?ph=true&h=300&w=458 "3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID")
| SpectraBase Compound ID | DXVbPV7Qw4r |
|---|---|
| InChI | InChI=1S/C20H30N2O5/c1-13(2)12-16(22-19(26)27-20(3,4)5)18(25)21-15-9-6-14(7-10-15)8-11-17(23)24/h6-7,9-10,13,16H,8,11-12H2,1-5H3,(H,21,25)(H,22,26)(H,23,24)/t16-/m0/s1 |
| InChIKey | POENTGADFNBGAW-INIZCTEOSA-N |
| Mol Weight | 378.47 g/mol |
| Molecular Formula | C20H30N2O5 |
| Exact Mass | 378.215472 g/mol |
| Enantiomer InChIKey | POENTGADFNBGAW-MRXNPFEDSA-N |
| Racemate InChIKey | POENTGADFNBGAW-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-(4-[N(ALPHA)-TERT.-BUTOXYCARBONYL-L-LEUCINOYLAMINO]-PHENYL)-PROPANOIC-ACID-METHYLESTER
benzyl 4-amino-1-(anilinocarbonyl)-4-oxobutylcarbamate
(2S)-2-[(4,4-DIMETHYL-3-OXOPENTYL)-AMINO]-N-(4-METHYLPHENYL)-3-PHENYLPROPANAMIDE
N-[(1S)-1-benzyl-2-(cyclohexylamino)-2-keto-ethyl]carbamic acid tert-butyl ester
N-[(1S)-1-benzyl-2-(benzylamino)-2-keto-ethyl]carbamic acid tert-butyl ester
Benzenepropanamide, N-(2-hydroxy-1-cyanoethyl)-.alpha.-(t-butoxycarbonylamino)-
T-Butoxycarbonyl-lysyl(T-butoxycarbonyl)-glycine benzyl ester
2-[[2-(tert-butoxycarbonylamino)-3-phenyl-propanoyl]amino]acetic acid [(E)-but-2-enyl] ester
Methyl (2S)-2-[(2S)-2-t-Butoxycarbonylaminohexadecanoylamino]propionate
Tert-Butyl (S)-{1-[Methoxy(methyl)amino]-1-oxo-3-phenylpropan-2-yl}carbamate
| Title | Journal or Book | Year |
|---|---|---|
| Design, Synthesis, and Pharmacological Evaluation of Thapsigargin Analogues for Targeting Apoptosis to Prostatic Cancer Cells | Journal of Medicinal Chemistry | 2001 |